PROVIDER PROFILE · NPI 1306027107

Edward Noonan

PRACTICEMARK R KAISER M D PASee all providers at this practice →

Physician AssistantStuart, FLI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

2,529

Beneficiaries

—

Total drug cost

$352K

Distinct drugs

Brand share

10.2%

Top prescribed drugs

Hydrocortisone498 claims

Triamcinolone Acetonide412 claims

Ketoconazole303 claims

Mupirocin271 claims

Doxycycline Hyclate145 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

100.0

Cost

52.7

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

1.05%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$445

Payment records

By payment type

Food and Beverage$350

Education$95

REFERRAL NETWORK

Where Edward Noonan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MARTIN MEMORIAL MEDICAL CENTER INC	79	150

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Francessca Brettschneider Pathology · Aventura, FL	132	159
Mark Kaiser Dermatology · Stuart, FL	116	649
MARTIN MEMORIAL MEDICAL CENTER INC	84	179
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Tampa, FL	28	39
Integrated Regional Laboratories, Llp Clinical Laboratory · Deerfield Beach, FL	13	26
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Miramar, FL	13	33

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history